{"id":"NCT03160521","sponsor":"Rovi Pharmaceuticals Laboratories","briefTitle":"Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia","officialTitle":"Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-06-02","primaryCompletion":"2018-12-17","completion":"2018-12-17","firstPosted":"2017-05-19","resultsPosted":"2022-02-04","lastUpdate":"2022-02-22"},"enrollment":438,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Schizophrenia"],"interventions":[{"type":"DRUG","name":"Risperidone ISM 75 mg","otherNames":["Risperidone ISM"]},{"type":"DRUG","name":"Risperidone ISM 100 mg","otherNames":["Risperidone ISM"]},{"type":"DRUG","name":"Placebo of Risperidone ISM","otherNames":["PLACEBO"]}],"arms":[{"label":"Risperidone ISM 75 mg","type":"EXPERIMENTAL"},{"label":"Risperidone ISM 100 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a multicenter, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of intramuscular (IM) injections of Risperidone ISM® (75 or 100 mg) or placebo, in patients with acute exacerbation of schizophrenia.","primaryOutcome":{"measure":"PANSS Total Score Mean Change From Baseline to Endpoint","timeFrame":"Day 1 (Baseline) and Day 85 (or the last post-baseline assessment)","effectByArm":[{"arm":"Risperidone ISM 75 mg","deltaMin":-24.6,"sd":1.51},{"arm":"Risperidone ISM 100 mg","deltaMin":-24.7,"sd":1.54},{"arm":"Placebo","deltaMin":-11,"sd":1.56}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":31,"countries":["United States","Ukraine"]},"refs":{"pmids":["33239746"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":144},"commonTop":["Blood prolactin increased","Headache","Hyperprolactinaemia","Weight increased","Akathisia"]}}